{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T19:20:33Z","timestamp":1772479233101,"version":"3.50.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,1,2]],"date-time":"2020-01-02T00:00:00Z","timestamp":1577923200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,2]],"date-time":"2020-01-02T00:00:00Z","timestamp":1577923200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1208\/s12249-019-1579-5","type":"journal-article","created":{"date-parts":[[2020,1,2]],"date-time":"2020-01-02T19:04:37Z","timestamp":1577991877000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Orodispersible Carbamazepine\/Hydroxypropyl-\u03b2-Cyclodextrin Tablets Obtained by Direct Compression with Five-in-One Co-processed Excipients"],"prefix":"10.1208","volume":"21","author":[{"given":"Jaime","family":"Concei\u00e7\u00e3o","sequence":"first","affiliation":[]},{"given":"Oluwatomide","family":"Adeoye","sequence":"additional","affiliation":[]},{"given":"Helena","family":"Cabral-Marques","sequence":"additional","affiliation":[]},{"given":"Angel","family":"Concheiro","sequence":"additional","affiliation":[]},{"given":"Carmen","family":"Alvarez-Lorenzo","sequence":"additional","affiliation":[]},{"given":"Jos\u00e9 Manuel","family":"Sousa Lobo","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2020,1,2]]},"reference":[{"issue":"13","key":"1579_CR1","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.2174\/1381612824666171218125431","volume":"24","author":"J Concei\u00e7\u00e3o","year":"2018","unstructured":"Concei\u00e7\u00e3o J, Adeoye O, Cabral-Marques HM, Lobo JMS. Cyclodextrins as drug carriers in pharmaceutical technology: the state of the art. Curr Pharm Des. 2018;24(13):1405\u201333.","journal-title":"Curr Pharm Des"},{"issue":"4","key":"1579_CR2","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1208\/s12249-014-0107-x","volume":"15","author":"M Narvekar","year":"2014","unstructured":"Narvekar M, Xue HY, Eoh JY, Wong HL. Nanocarrier for poorly water-soluble anticancer drugs\u2014barriers of translation and solutions. AAPS PharmSciTech. 2014;15(4):822\u201333.","journal-title":"AAPS PharmSciTech"},{"issue":"1\u20132","key":"1579_CR3","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.ijpharm.2017.11.018","volume":"535","author":"P Jansook","year":"2018","unstructured":"Jansook P, Ogawa N, Loftsson T. Cyclodextrins: structure, physicochemical properties and pharmaceutical applications. Int J Pharm. 2018;535(1\u20132):272\u201384.","journal-title":"Int J Pharm"},{"issue":"4","key":"1579_CR4","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1208\/s12249-011-9690-2","volume":"12","author":"PJ Sal\u00fastio","year":"2011","unstructured":"Sal\u00fastio PJ, Pontes P, Conduto C, Sanches I, Carvalho C, Arrais J, et al. Advanced technologies for oral controlled release: cyclodextrins for oral controlled release. AAPS PharmSciTech. 2011;12(4):1276\u201392.","journal-title":"AAPS PharmSciTech"},{"issue":"5","key":"1579_CR5","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/ddr.21452","volume":"79","author":"S Jacob","year":"2018","unstructured":"Jacob S, Nair AB. Cyclodextrin complexes: perspective from drug delivery and formulation. Drug Dev Res. 2018;79(5):201\u201317.","journal-title":"Drug Dev Res"},{"issue":"6","key":"1579_CR6","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/j.drudis.2018.04.009","volume":"23","author":"J Concei\u00e7\u00e3o","year":"2018","unstructured":"Concei\u00e7\u00e3o J, Adeoye O, Cabral-Marques HM, Lobo JMS. Cyclodextrins as excipients in tablet formulations. Drug Discov Today. 2018;23(6):1274\u201384.","journal-title":"Drug Discov Today"},{"issue":"2","key":"1579_CR7","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.ijpharm.2017.04.050","volume":"531","author":"O Adeoye","year":"2017","unstructured":"Adeoye O, Cabral-Marques H. Cyclodextrin nanosystems in oral drug delivery: a mini review. Int J Pharm. 2017;531(2):521\u201331.","journal-title":"Int J Pharm"},{"key":"1579_CR8","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ijpharm.2019.02.004","volume":"560","author":"T Loftsson","year":"2019","unstructured":"Loftsson T, Saokham P, S\u00e1 Couto AR. Self-association of cyclodextrins and cyclodextrin complexes in aqueous solutions. Int J Pharm. 2019;560:228\u201334.","journal-title":"Int J Pharm"},{"key":"1579_CR9","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.carbpol.2019.05.084","volume":"221","author":"J Concei\u00e7\u00e3o","year":"2019","unstructured":"Concei\u00e7\u00e3o J, Farto-Vaamonde X, Goyanes A, Adeoye O, Concheiro A, Cabral-Marques H, et al. Hydroxypropyl-\u03b2-cyclodextrin-based fast dissolving carbamazepine printlets prepared by semisolid extrusion 3D printing. Carbohydr Polym. 2019;221:55\u201362.","journal-title":"Carbohydr Polym"},{"key":"1579_CR10","unstructured":"European Pharmacopoeia, 9th edition. Strasbourg, France: European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe; 2016."},{"issue":"2","key":"1579_CR11","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.drudis.2017.10.003","volume":"23","author":"F Cilurzo","year":"2018","unstructured":"Cilurzo F, Musazzi UM, Franz\u00e9 S, Selmin F, Minghetti P. Orodispersible dosage forms: biopharmaceutical improvements and regulatory requirements. Drug Discov Today. 2018;23(2):251\u20139.","journal-title":"Drug Discov Today"},{"issue":"2","key":"1579_CR12","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1208\/s12249-016-0515-1","volume":"18","author":"JC Visser","year":"2017","unstructured":"Visser JC, Woerdenbag HJ, Hanff LM, Frijlink HW. Personalized medicine in pediatrics: the clinical potential of orodispersible films. AAPS PharmSciTech. 2017;18(2):267\u201372.","journal-title":"AAPS PharmSciTech"},{"key":"1579_CR13","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.ejps.2015.02.015","volume":"75","author":"M Slavkova","year":"2015","unstructured":"Slavkova M, Breitkreutz J. Orodispersible drug formulations for children and elderly. Eur J Pharm Sci. 2015;75:2\u20139.","journal-title":"Eur J Pharm Sci"},{"key":"1579_CR14","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ejpb.2017.10.018","volume":"122","author":"GF Petrovick","year":"2018","unstructured":"Petrovick GF, Kleinebudde P, Breitkreutz J. Orodispersible tablets containing taste-masked solid lipid pellets with metformin hydrochloride: influence of process parameters on tablet properties. Eur J Pharm Biopharm. 2018;122:137\u201345.","journal-title":"Eur J Pharm Biopharm"},{"issue":"2","key":"1579_CR15","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1208\/s12249-013-9973-x","volume":"14","author":"F Zeng","year":"2013","unstructured":"Zeng F, Wang L, Zhang W, Shi K, Zong L. Formulation and in vivo evaluation of orally disintegrating tablets of clozapine\/hydroxypropyl-\u03b2-cyclodextrin inclusion complexes. AAPS PharmSciTech. 2013;14(2):854\u201360.","journal-title":"AAPS PharmSciTech"},{"issue":"40","key":"1579_CR16","doi-asserted-by":"crossref","first-page":"5877","DOI":"10.2174\/1381612821666151008125117","volume":"21","author":"S Mangal","year":"2015","unstructured":"Mangal S, Meiser F, Morton D, Larson I. Particle engineering of excipients for direct compression: understanding the role of material properties. Curr Pharm Des. 2015;21(40):5877\u201389.","journal-title":"Curr Pharm Des"},{"issue":"6","key":"1579_CR17","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1208\/s12249-018-1090-4","volume":"19","author":"BJ Bowles","year":"2018","unstructured":"Bowles BJ, Dziemidowicz K, Lopez FL, Orlu M, Tuleu C, Edwards AJ, et al. Co-processed excipients for dispersible tablets\u2014part 1: manufacturability. AAPS PharmSciTech. 2018;19(6):2598\u2013609.","journal-title":"AAPS PharmSciTech"},{"issue":"1","key":"1579_CR18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v23.i1.10","volume":"23","author":"S Patel","year":"2006","unstructured":"Patel S, Kaushal AM, Bansal AK. Compression physics in the formulation development of tablets. Crit Rev Ther Drug Carrier Syst. 2006;23(1):1\u201365.","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"issue":"6","key":"1579_CR19","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1208\/s12249-018-1104-2","volume":"19","author":"K Dziemidowicz","year":"2018","unstructured":"Dziemidowicz K, Lopez FL, Bowles BJ, Edwards AJ, Ernest TB, Orlu M, et al. Co-processed excipients for dispersible tablets\u2014part 2: patient acceptability. AAPS PharmSciTech. 2018;19(6):2646\u201357.","journal-title":"AAPS PharmSciTech"},{"issue":"4","key":"1579_CR20","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1208\/s12249-012-9831-2","volume":"13","author":"A Krupa","year":"2012","unstructured":"Krupa A, Jachowicz R, P\u0119dzich Z, Wodnicka K. The influence of the API properties on the ODTs manufacturing from co-processed excipient systems. AAPS PharmSciTech. 2012;13(4):1120\u20139.","journal-title":"AAPS PharmSciTech"},{"key":"1579_CR21","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.ijpharm.2018.11.071","volume":"556","author":"CRS Siow","year":"2019","unstructured":"Siow CRS, Tang DS, Heng PWS, Chan LW. Probing the impact of HPMC viscosity grade and proportion on the physical properties of co-freeze-dried mannitol-HPMC tableting excipients using multivariate analysis methods. Int J Pharm. 2019;556:246\u201362.","journal-title":"Int J Pharm"},{"issue":"6","key":"1579_CR22","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1080\/10837450.2019.1596131","volume":"24","author":"SM Assaf","year":"2019","unstructured":"Assaf SM, Subhi Khanfar M, Bassam Farhan A, Said Rashid I, Badwan AA. Preparation and characterization of co-processed starch\/MCC\/chitin hydrophilic polymers onto magnesium silicate. Pharm Dev Technol. 2019;24(6):761\u201374.","journal-title":"Pharm Dev Technol"},{"issue":"5","key":"1579_CR23","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1080\/03639045.2019.1569675","volume":"45","author":"P Rathod","year":"2019","unstructured":"Rathod P, Mori D, Parmar R, Soniwala M, Chavda J. Co-processing of cefuroxime axetil by spray drying technique for improving compressibility and flow property. Drug Dev Ind Pharm. 2019;45(5):767\u201374.","journal-title":"Drug Dev Ind Pharm"},{"issue":"2","key":"1579_CR24","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1517\/17425240802708978","volume":"6","author":"S Saha","year":"2009","unstructured":"Saha S, Shahiwala AF. Multifunctional coprocessed excipients for improved tabletting performance. Expert Opin Drug Deliv. 2009;6(2):197\u2013208.","journal-title":"Expert Opin Drug Deliv"},{"issue":"10","key":"1579_CR25","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.3109\/03639045.2011.645833","volume":"38","author":"J Rojas","year":"2012","unstructured":"Rojas J, Buckner I, Kumar V. Co-proccessed excipients with enhanced direct compression functionality for improved tableting performance. Drug Dev Ind Pharm. 2012;38(10):1159\u201370.","journal-title":"Drug Dev Ind Pharm"},{"issue":"4","key":"1579_CR26","doi-asserted-by":"crossref","first-page":"426","DOI":"10.2174\/156720111795767960","volume":"8","author":"AG Mirani","year":"2011","unstructured":"Mirani AG, Patankar SP, Borole VS, Pawar AS, Kadam VJ. Direct compression high functionality excipient using coprocessing technique: a brief review. Curr Drug Deliv. 2011;8(4):426\u201335.","journal-title":"Curr Drug Deliv"},{"issue":"10","key":"1579_CR27","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1517\/17460441.2014.941802","volume":"9","author":"A Al-Khattawi","year":"2014","unstructured":"Al-Khattawi A, Mohammed AR. Challenges and emerging solutions in the development of compressed orally disintegrating tablets. Expert Opin Drug Discovery. 2014;9(10):1109\u201320.","journal-title":"Expert Opin Drug Discovery"},{"issue":"5","key":"1579_CR28","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1517\/17425247.2013.769955","volume":"10","author":"A Al-Khattawi","year":"2013","unstructured":"Al-Khattawi A, Mohammed AR. Compressed orally disintegrating tablets: excipients evolution and formulation strategies. Expert Opin Drug Deliv. 2013;10(5):651\u201363.","journal-title":"Expert Opin Drug Deliv"},{"issue":"7","key":"1579_CR29","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1517\/14656566.2016.1168399","volume":"17","author":"J Gierbolini","year":"2016","unstructured":"Gierbolini J, Giarratano M, Benbadis SR. Carbamazepine-related antiepileptic drugs for the treatment of epilepsy\u2014a comparative review. Expert Opin Pharmacother. 2016;17(7):885\u20138.","journal-title":"Expert Opin Pharmacother"},{"key":"1579_CR30","first-page":"117","volume":"4","author":"T Higuchi","year":"1965","unstructured":"Higuchi T, Connors KA. Phase solubility techniques. Adv Anal Chem Instrum. 1965;4:117\u2013212.","journal-title":"Adv Anal Chem Instrum"},{"key":"1579_CR31","unstructured":"United States Pharmacopeia (USP) 41 - National Formulary (NF) 36. Rockville, United States of America: The United States Pharmacopeial Convention; 2017."},{"issue":"9","key":"1579_CR32","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1002\/jps.23077","volume":"101","author":"T Loftsson","year":"2012","unstructured":"Loftsson T, Brewster ME. Cyclodextrins as functional excipients: methods to enhance complexation efficiency. J Pharm Sci. 2012;101(9):3019\u201332.","journal-title":"J Pharm Sci"},{"key":"1579_CR33","unstructured":"Kleptose\u00ae: betacyclodextrins and hydroxypropyl betacyclodextrins: Roquette; 2006."},{"issue":"6","key":"1579_CR34","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1208\/s12249-018-1115-z","volume":"19","author":"J Concei\u00e7\u00e3o","year":"2018","unstructured":"Concei\u00e7\u00e3o J, Adeoye O, Cabral-Marques HM, Sousa Lobo JM. Hydroxypropyl-\u03b2-cyclodextrin and \u03b2-cyclodextrin as tablet fillers for direct compression. AAPS PharmSciTech. 2018;19(6):2710\u20138.","journal-title":"AAPS PharmSciTech"},{"key":"1579_CR35","first-page":"111","volume":"66","author":"J Concei\u00e7\u00e3o","year":"2016","unstructured":"Concei\u00e7\u00e3o J, Teixeira C, Sousa G, Sim\u00f5es AM, Amorim A, S\u00e1 B, et al. Tablet machine instrumentation: influence of lubricants on the lubrication efficiency and compaction profiles. Arh Farm. 2016;66:111\u20132.","journal-title":"Arh Farm"},{"key":"1579_CR36","unstructured":"Concei\u00e7\u00e3o J, Sousa G, Teixeira C, Sim\u00f5es AM, S\u00e1 B, Sousa Lobo JM. Influence of lubricants on tabletting and drug release characteristics. In: 10th world meeting on pharmaceutics, biopharmaceutics and pharmaceutical technology; Glasgow: APV, APGI and A.D.R.I.T.E.L.F; 2016."},{"issue":"8","key":"1579_CR37","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.3109\/10717544.2016.1138340","volume":"23","author":"HA Moqbel","year":"2016","unstructured":"Moqbel HA, ElMeshad AN, El-Nabarawi MA. A pharmaceutical study on chlorzoxazone orodispersible tablets: formulation, in-vitro and in-vivo evaluation. Drug Deliv. 2016;23(8):2998\u20133007.","journal-title":"Drug Deliv"},{"issue":"6","key":"1579_CR38","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1208\/s12248-017-0149-6","volume":"19","author":"P Kohlmann","year":"2017","unstructured":"Kohlmann P, Stillhart C, Kuentz M, Parrott N. Investigating oral absorption of carbamazepine in pediatric populations. AAPS J. 2017;19(6):1864\u201377.","journal-title":"AAPS J"},{"issue":"7","key":"1579_CR39","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1208\/s12249-017-0715-3","volume":"18","author":"P Chandrasekaran","year":"2017","unstructured":"Chandrasekaran P, Kandasamy R. Development of extended-release oral flexible tablet (ER-OFT) formulation for pediatric and geriatric compliance: an age-appropriate formulation. AAPS PharmSciTech. 2017;18(7):2394\u2013409.","journal-title":"AAPS PharmSciTech"},{"key":"1579_CR40","unstructured":"European Medicines Agency (EMA), Committee for Human Medicinal Products (CHMP). Background review for cyclodextrins used as excipients. London; 2014. https:\/\/www.ema.europa.eu\/en\/documents\/report\/background-review-cyclodextrins-used-excipients-context-revision-guideline-excipients-label-package_en.pdf."},{"issue":"1\u20132","key":"1579_CR41","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ijpharm.2011.02.042","volume":"409","author":"W Kou","year":"2011","unstructured":"Kou W, Cai C, Xu S, Wang H, Liu J, Yang D, et al. In vitro and in vivo evaluation of novel immediate release carbamazepine tablets: complexation with hydroxypropyl-\u03b2-cyclodextrin in the presence of HPMC. Int J Pharm. 2011;409(1\u20132):75\u201380.","journal-title":"Int J Pharm"},{"issue":"1","key":"1579_CR42","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0939-6411(02)00127-3","volume":"55","author":"LS Koester","year":"2003","unstructured":"Koester LS, Xavier CR, Mayorga P, Bassani VL. Influence of beta-cyclodextrin complexation on carbamazepine release from hydroxypropyl methylcellulose matrix tablets. Eur J Pharm Biopharm. 2003;55(1):85\u201391.","journal-title":"Eur J Pharm Biopharm"},{"issue":"4","key":"1579_CR43","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.ajps.2016.02.009","volume":"11","author":"GOK Loh","year":"2016","unstructured":"Loh GOK, Tan YTF, Peh K-K. Enhancement of norfloxacin solubility via inclusion complexation with \u03b2-cyclodextrin and its derivative hydroxypropyl-\u03b2-cyclodextrin. Asian J Pharm Sci. 2016;11(4):536\u201346.","journal-title":"Asian J Pharm Sci"},{"key":"1579_CR44","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.jpba.2015.01.058","volume":"113","author":"P Mura","year":"2015","unstructured":"Mura P. Analytical techniques for characterization of cyclodextrin complexes in the solid state: a review. J Pharm Biomed Anal. 2015;113:226\u201338.","journal-title":"J Pharm Biomed Anal"},{"issue":"4","key":"1579_CR45","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1208\/s12249-011-9685-z","volume":"12","author":"AS Jain","year":"2011","unstructured":"Jain AS, Date AA, Pissurlenkar RR, Coutinho EC, Nagarsenker MS. Sulfobutyl ether(7) \u03b2-cyclodextrin (SBE(7) \u03b2-CD) carbamazepine complex: preparation, characterization, molecular modeling, and evaluation of in vivo anti-epileptic activity. AAPS PharmSciTech. 2011;12(4):1163\u201375.","journal-title":"AAPS PharmSciTech"},{"issue":"1","key":"1579_CR46","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0168-3659(98)00002-9","volume":"54","author":"I Katzhendler","year":"1998","unstructured":"Katzhendler I, Azoury R, Friedman M. Crystalline properties of carbamazepine in sustained release hydrophilic matrix tablets based on hydroxypropyl methylcellulose. J Control Release. 1998;54(1):69\u201385.","journal-title":"J Control Release"},{"key":"1579_CR47","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ejps.2015.08.001","volume":"78","author":"D Medarevi\u0107","year":"2015","unstructured":"Medarevi\u0107 D, Kachrimanis K, Djuri\u0107 Z, Ibri\u0107 S. Influence of hydrophilic polymers on the complexation of carbamazepine with hydroxypropyl-\u03b2-cyclodextrin. Eur J Pharm Sci. 2015;78:273\u201385.","journal-title":"Eur J Pharm Sci"},{"issue":"1","key":"1579_CR48","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ejpb.2010.12.022","volume":"78","author":"PJ Sal\u00fastio","year":"2011","unstructured":"Sal\u00fastio PJ, Cabral-Marques HM, Costa PC, Pinto JF. Comparison of ibuprofen release from minitablets and capsules containing ibuprofen: \u03b2-cyclodextrin complex. Eur J Pharm Biopharm. 2011;78(1):58\u201366.","journal-title":"Eur J Pharm Biopharm"},{"key":"1579_CR49","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s10847-012-0151-7","volume":"75","author":"PJ Sal\u00fastio","year":"2013","unstructured":"Sal\u00fastio PJ, Pinto JF, Costa PC, Cabral-Marques HM. Release profiles of indometacin in \u03b2-cyclodextrin complexes from HPMC capsules. J Incl Phenom Macrocycl Chem. 2013;75:101\u20139.","journal-title":"J Incl Phenom Macrocycl Chem"},{"key":"1579_CR50","first-page":"109","volume":"66","author":"J Concei\u00e7\u00e3o","year":"2016","unstructured":"Concei\u00e7\u00e3o J, S\u00e1 B, Vaz Q, Mesquita P, Sousa G, Sousa Lobo JM. Effect of superdisintegrants on dissolution rate and disintegration time. Arh Farm. 2016;66:109\u201310.","journal-title":"Arh Farm"},{"key":"1579_CR51","unstructured":"Guidance for industry: orally disintegrating tablets: Food and Drug Administration (FDA); 2008."},{"issue":"2","key":"1579_CR52","doi-asserted-by":"crossref","first-page":"97","DOI":"10.4103\/0973-8398.55046","volume":"3","author":"NGR Rao","year":"2009","unstructured":"Rao NGR, Patel T, Gandhi S. Development and evaluation of carbamazepine fast dissolving tablets prepared with a complex by direct compression technique. Asian J Pharm. 2009;3(2):97\u2013103.","journal-title":"Asian J Pharm"},{"issue":"5","key":"1579_CR53","doi-asserted-by":"crossref","first-page":"633","DOI":"10.4155\/tde.12.28","volume":"3","author":"H Arima","year":"2012","unstructured":"Arima H, Higashi T, Motoyama K. Improvement of the bitter taste of drugs by complexation with cyclodextrins: applications, evaluations and mechanisms. Ther Deliv. 2012;3(5):633\u201344.","journal-title":"Ther Deliv"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-019-1579-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1208\/s12249-019-1579-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-019-1579-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,24]],"date-time":"2021-03-24T18:09:39Z","timestamp":1616609379000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1208\/s12249-019-1579-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,2]]},"references-count":53,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["1579"],"URL":"https:\/\/doi.org\/10.1208\/s12249-019-1579-5","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,2]]},"assertion":[{"value":"27 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"39"}}